EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 27-Oct-2026 04:16 ET (27-Oct-2026 08:16 GMT/UTC)

27-Aug-2026

Almost a third of women in their 20s have never been screened for cervical cancer

Medical University of South Carolina
Peer-Reviewed Publication

The percentage of women who report never having been screened for cervical cancer increased from 2005 to 2023.

Journal: JAMA Network Open

27-Aug-2026

Rates of never receiving cervical cancer screening among US women, 2005-2023

JAMA Network
Peer-Reviewed Publication

In this cross-sectional study, the proportion of US women who reported never having undergone cervical cancer screening increased from 2005 to 2023 in both ages 21 to 29 years and 30 to 65 years. The findings identified sociodemographic disparities in never-screening.

Journal: JAMA Network Open

27-Aug-2026

Cancer biosimilars associated with lower costs for insurers and patients, UCLA study finds

University of California - Los Angeles Health Sciences
Peer-Reviewed Publication

Biologic drugs play an important role in treating cancers such as breast cancer and lymphoma, but their high costs can add to the financial burden of cancer care. Now, lower-cost versions known as biosimilars are gaining ground, and a new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center suggests their growing use is associated with lower costs for both insurers and patients.

Journal: JAMA Oncology

27-Aug-2026

Boston Medical Center and Boston University researchers develop scalable method to generate key immune cells for cancer therapy

Boston Medical Center
Peer-Reviewed Publication

Researchers at the Center for Regenerative Medicine (CReM) at Boston Medical Center (BMC) and Boston University (BU) have developed a scalable method for generating CD4+ helper T cells from induced pluripotent stem cells (iPSCs), overcoming a longstanding challenge in the development of stem cell-based immunotherapies. The findings could help advance efforts to create off-the-shelf CAR-T cell therapies that can be produced at scale and made more readily available to patients.

Journal: Stem Cell Reports

27-Aug-2026

Phosvitin, a potential neuroprotectant against reactive oxygen species in nerve cells

Tsinghua University Press
Peer-Reviewed Publication

Phosvitin, a rich phosphoprotein found in egg yolks, is the starting material for phosvitin phosphopeptides (PPPs), a powerful and potentially impactful dietary delivery agent to relieve oxidative stress that can lead to neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases. Results show promise with PPPs, including increasing cell viability, free-radical reduction and inhibitory activities that promote cell protection.

Journal: Food Science of Animal Products

27-Aug-2026

ACS report reveals Native Hawaiian women in U.S. have highest breast cancer incidence; wide variation in cancer risk among Asian American, Native Hawaiian and Pacific Islander population

American Cancer Society
Peer-Reviewed Publication

Cancer data for Asian American and Native Hawaiian and Pacific Islander (NHPI) people are usually combined, hiding vast differences in cancer risk. New disaggregated data analyzed by researchers at the American Cancer Society (ACS) shows that Native Hawaiian women have 27% higher breast cancer incidence than White women, and have the highest rates in the U.S. when Asian American and NHPI women are not combined. Disaggregated data breaks down differences among Asian American and NHPI ethnic groups that would not have been apparent if the data were combined.

Journal: Cancer

27-Aug-2026

Nanoparticle-based cancer treatment awarded $2.5 million

University of Massachusetts Amherst
Grant and Award Announcement

AMHERST, Mass. — Having established the effectiveness of her nanoparticle drug-delivery system for cancer immunotherapy, University of Massachusetts Amherst researcher Prabhani Atukorale, has been awarded $2.5 million from the National Institutes of Health to broaden the scope of her vaccine research to include treating those with active cancer.

27-Aug-2026

Alliance to showcase vital role of clinical trials in new film

Alliance for Clinical Trials in Oncology
Business Announcement

The Alliance for Clinical Trials in Oncology has released a film highlighting the critical role of participant involvement in advancing cancer research and improving care.

27-Aug-2026

Pusan National University develops injectable microgels for targeted keloid radiotherapy

Pusan National University
Peer-Reviewed Publication

Researchers in Korea are developing a new approach to localized brachytherapy that could improve the treatment of keloid scars. The strategy uses injectable, biodegradable hyaluronic acid microgels that act as tiny radiation reservoirs within target tissue. By combining rapid radiolabeling with localized delivery, the platform aims to overcome limitations of conventional radiation treatment while offering greater flexibility and precision. The study highlights a promising step toward targeted, minimally invasive microbrachytherapy.

Journal: Journal of Controlled Release

27-Aug-2026

Prospective multicenter study of first-line stem cell mobilization with EAP regimen in multiple myeloma and lymphoma

Chinese Medical Journals Publishing House Co., Ltd.
Peer-Reviewed Publication

This prospective multicenter phase II study evaluated optimized EAP as first-line stem cell mobilization for myeloma and lymphoma. It achieved excellent collection efficacy, acceptable hematologic toxicity, and favorable post-transplant outcomes.

Journal: Chinese Medical Journal
Funder: Zhejiang Provincial Medical and Health Science and Technology Project, Ningbo Public Welfare Science and Technology Program, Ningbo Top Medical and Health Research Program, Ningbo "Innovation Yongjiang 2035" Key Technology Breakthrough Program, Natural Science Foundation of Zhejiang Province Project